NEI Podcast

Latest Episodes:

E231 - The 2023 NEI Congress Young Investigator Poster Competition #1 Poster with Dr. Richard Price Aug 07, 2024

Show notes

Join Dr. Andy Cutler as he talks with the co-author of the winning poster from the 2023 NEI Congress Young Investigator Poster Competition, Dr. Richard Price. They discuss the objectives, design, and key findings of the poster titled, "Improved Mood and Weight Gain Mitigation Following Switch from Aripiprazole to Cariprazine." They also discuss the potential implications of these findings and applications of cariprazine in psychiatry.

Dr. Richard Price is an Assistant Professor of Clinical Psychiatry at Weill Cornell Medical College. Maxwell Zachary Price, the lead author of the winning poster, is a medical student at Hackensack Meridian School of Medicine.

Learn about upcoming NEI Meetings at https://nei.global/meetings

E230 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: MAOIs with Dr. Thomas Schwartz Jul 17, 2024

Show notes

What are the main reasons MAOIs are underutilized in psychiatric practice despite their proven efficacy for certain conditions? What are the key dietary restrictions patients must follow when taking MAOIs? What are the critical drug-drug interactions clinicians must be aware of when prescribing MAOIs? What clinical pearls or tips would you give to clinicians looking to become more comfortable using these agents?

Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of themes. This theme is on underutilized psychotropic drugs.

Today, Dr. Andy Cutler interviews Dr. Thomas Schwartz and Dr. Stephen Stahl about factors that have led to the underutilization of MAOIs in psychiatry.

Let's listen to Part 2 of our theme: Underutilized Psychiatric Drugs.

Subscribe to the NEI Podcast, so that you don't miss another episode!

Resources

Email roundtable@maoiexperts.topicbox.com for guidance on prescribing MAO inhibitors

The Prescriber's Guide to Classic MAO Inhibitors (Phenelzine, Tranylcypromine, Isocarboxazid) for Treatment-Resistant Depression

Practical Guide for Prescribing MAOIs: Debunking Myths and Removing Barriers

E229 - Treatment Approaches for Smoking Cessation in the LGBTQIA+ Community with Dr. Rhonda Schwindt Jul 03, 2024

Show notes

What are the current smoking rates among LGBTQIA+ individuals compared to the general population? What unique barriers do LGBTQIA+ individuals face when trying to quit smoking? What are the recommended pharmacotherapies and behavioral interventions for smoking cessation? What training is needed for providers to deliver culturally affirmative smoking cessation treatment for LGBTQIA+ patients?

Dr. Rhonda Schwindt is an Associate Professor at The George Washington University School of Nursing. She is a nationally certified Psychiatric-Mental Health Nurse Practitioner with an active clinical practice specializing in LGBTQIA+ health, trauma, and treatment-resistant mood disorders. Dr. Schwindt earned a Doctor of Nursing Practice degree from Case Western Reserve University, a Master of Science in Nursing from Indiana University School of Nursing, a Bachelor of Arts from Purdue University, and a diploma in nursing from St. Elizabeth School of Nursing. Dr. Schwindt has a funded program of research focused on improving health outcomes for the LGBTQIA+ community. She led a team of researchers that examined barriers to, and facilitators of, smoking cessation and treatment utilization in the transgender and gender expansive population as well as studies exploring best practices for teaching graduate students how to provide affirming care. Dr. Schwindt has received international recognition as an outstanding graduate nurse educator and for clinical excellence in the care of persons living with serious mental illness.

Resources

Pride in Being Tobacco-Free

UCSF Smoking Cessation Leadership Center

Fenway Health

Trevor Project

E228 - (CME) Tardive Dyskinesia Today: Updates in the Current Landscape of Tardive Dyskinesia Jun 26, 2024

Show notes

In this CME episode, Dr. Andrew Cutler interviews Dr. Laxman Bahroo about the current landscape of tardive dyskinesia, including screening, diagnosis, and treatment. Practical strategies based on the latest data are reviewed at length, particularly for long-term management of tardive dyskinesia.

Create a free NEI guest account and obtain CME/CE by participating in this activity here: https://nei.global/e228-cme

Never miss an episode!🎙SUBSCRIBE to the NEI Podcast– available on all your favorite platforms: https://nei.global/podcast

Interested in Psychopharmacology? Learn about the NEI Master Psychopharmacology Program: https://nei.global/mpp

Stay updated with email alerts and join our conversations on social. Follow us on:

YouTube: https://nei.global/youtube

Instagram: https://nei.global/instagram

LinkedIn: https://nei.global/linkedin

Facebook: https://nei.global/facebook

X: https://nei.global/twitter

E227 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: Lithium with Dr. Jonathan Meyer Jun 19, 2024

Show notes

What are the properties of lithium that make it a unique treatment option? What are the main reasons why lithium is underutilized in clinical practice, and what are the consequences of underutilization? What are the common myths or misconceptions about lithium's safety and tolerability? How can we better educate patients about the benefits of lithium and address concerns about side effects or monitoring requirements that may impact adherence?

Today, Dr. Andy Cutler interviews Dr. Jonathan Meyer and Dr. Stephen Stahl about factors that have led to the underutilization of lithium in psychiatry.

Let's listen to Part 1 of our theme: Underutilized Psychiatric Drugs.

Subscribe to the NEI Podcast, so that you don't miss another episode!

Resource

The Lithium Handbook

E226 - (CME) Symptoms Speak: Engaging Patients in the Tardive Dyskinesia Conversation Jun 05, 2024

Show notes

In this CME episode, Dr. Andrew Cutler interviews Desiree Matthews, PMHNP-BC on the importance of engaging patients across all facets of tardive dyskinesia management beginning with screening to symptoms monitoring to treatment. The role of patient experience and preferences in shared decision-making regarding treatment for tardive dyskinesia is discussed at length.

Create a free NEI guest account and obtain CME/CE by participating in this activity here: https://nei.global/e226-cme

Never miss an episode!🎙SUBSCRIBE to the NEI Podcast– available on all your favorite platforms: https://nei.global/podcast

Interested in Psychopharmacology? Learn about the NEI Master Psychopharmacology Program: https://nei.global/mpp

Stay updated with email alerts and join our conversations on social. Follow us on:

YouTube: https://nei.global/youtube

Instagram: https://nei.global/instagram

LinkedIn: https://nei.global/linkedin

Facebook: https://nei.global/facebook

X: https://nei.global/twitter

E225 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Agitation with Dr. Leslie Citrome May 15, 2024

Show notes

How do symptoms of agitation manifest differently in disorders such as bipolar disorder, schizophrenia, and dementia, and what challenges does this pose for assessment? What are the most effective pharmacological treatments for acute agitation in psychiatric patients, and how do you determine the best course of action? How do cultural factors influence the approach to managing agitation in various mental health conditions?

Today, Dr. Andy Cutler interviews Dr. Leslie Citrome and Dr. Stephen Stahl about the clinical difficulties of treating agitation.

Let's listen to Part 3 of our theme: Untreatable Dimensions of Psychopathology.

Subscribe to the NEI Podcast, so that you don't miss another episode!

E224 - Is Cannabidiol Useful for the Treatment of Opioid Use Disorder? with Dr. Joji Suzuki May 01, 2024

Show notes

What are the hypothesized neurobiological mechanisms that support the use of cannabidiol (CBD) as a treatment for opioid use disorder (OUD)? How does CBD influence cue-induced craving in OUD? What are the challenges and opportunities in further exploring the use of CBD as a potential treatment for OUD?

Dr. Joji Suzuki is the Director of the Division of Addiction Psychiatry and Director of Addictions Education in the Department of Psychiatry, Brigham and Women's Hospital, and an Assistant Professor of Psychiatry at Harvard Medical School. His areas of clinical and research interests are the assessment and management of substance use disorders and related conditions in general medical settings, motivational interviewing, office-based opioid treatment, implementation of collaborative models of care, and medical education. He is the site director for the Partners Addiction Psychiatry Fellowship, and is involved with teaching medical students, residents, and allied health professionals. He has authored over 30 peer-reviewed manuscripts and book chapters related to addiction psychiatry.

E223 - 2024 NEI Synapse Extended Q&A: Diagnosing and Treating Comorbid ADHD and Bipolar Disorder with Dr. David Goodman Apr 24, 2024

Show notes

In this episode, Dr. David Goodman addresses your unanswered questions from his presentation, Setting the Mood: Strategies for Diagnosing and Treating ADHD in the Context of Bipolar Disorder, delivered at 2024 NEI Synapse in Las Vegas, Nevada.

E222 - 2024 NEI Synapse Extended Q&A: Recognizing and Treating Mixed Features Across the Lifespan with Dr. Manpreet Singh Apr 21, 2024

Show notes

In this episode, Dr. Manpreet Singh addresses your unanswered questions from her joint presentation, Don't Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan, delivered at 2024 NEI Synapse in Las Vegas, Nevada.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected